Hyperoxia and acute lung injury.
Fisher
Aron B
AB
Beers
Michael F
MF
D000208:Acute Disease; D000818:Animals; D001761:Bleomycin / Q000633:toxicity; D018925:Chemokines / Q000502:physiology; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000187:drug effects / Q000293:injuries; D004731:Endotoxins / Q000633:toxicity; D006801:Humans; D018496:Hyperoxia / Q000150:complications; D007113:Immunity, Innate; D008168:Lung / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D055370:Lung Injury; D051379:Mice; D009569:Nitric Oxide / Q000502:physiology; D019301:Oleic Acid / Q000633:toxicity; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000293:injuries; D019707:Receptors, Chemokine / Q000502:physiology; D012121:Respiration, Artificial / Q000009:adverse effects; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D012307:Risk Factors; D018805:Sepsis / Q000150:complications; D013045:Species Specificity
D018925:Chemokines; D004731:Endotoxins; D019707:Receptors, Chemokine; D001761:Bleomycin; D019301:Oleic Acid; D009569:Nitric Oxide